Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians

Abstract Background and Aims In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. Methods PubMed database and Google Scholar were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19’up to 31ST March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India were accessed. Results We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. Conclusions Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.

[1]  R. Pranata,et al.  A wave of non-communicable diseases following the COVID-19 pandemic , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[2]  Fabien Maldonado,et al.  CoronaVirus Disease 2019: Withdrawing Mechanical Ventilation to Reallocate Life Support Under Crisis Standards of Care—Nonequivalence of the Equivalence Thesis , 2020, Critical care medicine.

[3]  Anoop Misra,et al.  "Diabetes care at doorsteps": A customised mobile van for the prevention, screening, detection and management of diabetes in the urban underprivileged populations of Delhi. , 2019, Diabetes & metabolic syndrome.

[4]  Yun-kai Zhai,et al.  Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis , 2014, Medicine.

[5]  S. Issac Niwas,et al.  Telemedicine and tele-health services for cancer-care delivery in India , 2008, IET Commun..

[6]  A. Farmer,et al.  Interactive telemedicine: effects on professional practice and health care outcomes. , 2015, The Cochrane database of systematic reviews.

[7]  Gunjan Saxena,et al.  E-medicine in India: - Hurdles and future prospects , 2003 .

[8]  S. Anoop,et al.  Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[9]  P. Schwarz,et al.  Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses , 2020, Journal of medical Internet research.

[10]  Raju Vaishya,et al.  Redefining diabetic foot disease management service during COVID-19 pandemic , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[11]  Raju Vaishya,et al.  Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[12]  Ritesh Gupta,et al.  Clinical considerations for patients with diabetes in times of COVID-19 epidemic , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[13]  Seewon Ryu.  Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2) , 2012, Healthcare Informatics Research.

[14]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.